Marshall Wace’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-110,000
Closed -$11.5M 2021
2020
Q2
$11.5M Buy
+110,000
New +$11.8M 0.08% 249

Other funds holding BSX.PRA

Marshall Wace's BSX.PRA Position: Q3 2020 in Review

Marshall Wace sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q3 2020, closing a stake of 110,000 shares — an estimated $11.5M sold.

Marshall Wace first reported a position in BSX.PRA in Q2 2020 and held it in 1 quarter. The position peaked at $11.5M in Q2 2020. 43 funds tracked by Wall St. Rank hold BSX.PRA as of Q3 2020.

  • Marshall Wace reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q3 2020 after selling out during the quarter.
  • Marshall Wace sold 110,000 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q3 2020, an estimated $11.5M.
  • Marshall Wace first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 1 quarter.
  • Marshall Wace's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $11.5M in Q2 2020.
  • 43 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q3 2020.

Based on Marshall Wace's 13F filing for Q3 2020, filed 16 Nov 2020.